ECU
RVMD icon

Eisler Capital (US)’s Revolution Medicines RVMD Stock Holding History

Eisler Capital (US)’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-21,395
Closed -$830K – 639
2024
Q2 		$830K Sell
21,395
-1,182
-5% -$44.2K 0.01% 487
2024
Q1 		$728K Buy
+22,577
New +$669K 0.02% 383

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Eisler Capital (US)'s RVMD Position: Q3 2024 in Review

Eisler Capital (US) sold out of Revolution Medicines (RVMD) in Q3 2024, closing a stake of 21,395 shares — an estimated $830K sold.

Eisler Capital (US) first reported a position in RVMD in Q1 2024 and held it in 2 quarters. The position peaked at $830K in Q2 2024. 255 funds tracked by Wall St. Rank hold RVMD as of Q3 2024.

  • Eisler Capital (US) reported no remaining Revolution Medicines position as of Q3 2024 after selling out during the quarter.
  • Eisler Capital (US) sold 21,395 Revolution Medicines shares in Q3 2024, an estimated $830K.
  • Eisler Capital (US) first reported a position in Revolution Medicines in Q1 2024 and held it in 2 quarters.
  • Eisler Capital (US)'s Revolution Medicines position peaked at $830K in Q2 2024.
  • 255 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2024.

Based on Eisler Capital (US)'s 13F filing for Q3 2024, filed 14 Nov 2024.